eFFECTOR Therapeutics, Inc. Deferred Tax Assets, Gross
eFFECTOR Therapeutics, Inc. had Deferred Tax Assets, Gross of $64.65 million as of 2023-12-31, per its 10-K filed 2024-03-26.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2024-03-26
- 2023-12-31: Deferred Tax Assets, Gross $64.65M.
- 2022-12-31: Deferred Tax Assets, Gross $56.67M.
- 2021-12-31: Deferred Tax Assets, Gross $48.94M.
- 2020-12-31: Deferred Tax Assets, Gross $40.42M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2023-12-31 | $64.65M 10-K · filed 2024-03-26 |
| 2022-12-31 | $56.67M 10-K · filed 2024-03-26 |
| 2021-12-31 | $48.94M 10-K · filed 2023-03-08 |
| 2020-12-31 | $40.42M 10-K · filed 2022-03-16 |